Novacyt (LSE:NCYT)
Novacyt is an international diagnostics group with a portfolio of cancer and infectious disease products and services.
About
Last updated 26-10-2021, 04:30:00pm BSTRelated Articles
-
The Novacyt (LON:NCYT) share price continues to tumble on delays
The Novacyt (LON:NCYT) share price continues to decline after pandemic disruptions cause a six-month delay in new product launches. Read More »
-
Is this why the Novacyt share price keeps falling?
Rupert Hargreaves explains why the Novacyt share price is sliding and could remain under pressure as the company's profits fall. Read More »
-
What’s going on with the Novacyt (NCYT) share price?
After months of decline, the Novacyt (NCYT) share price started rising last month. Is this a sign to buy? Zaven Boyrazian takes a closer... Read More »
-
3 dirt-cheap AIM stocks. Should I buy?
Paul Summers picks out three lowly-valued AIM stocks that could turn out to be huge bargains in time. But are the risks too great... Read More »
-
The Novacyt (NCYT) share price: is it set to soar again?
The Novacyt share price (LON: NCYT) collapsed earlier in 2021. But the latest news has sent it heading upwards again. Time to buy? Read More »
-
Is the Novacyt (NCYT) share price about to bounce back?
The Novacyt share price is rising today. Is the worst over for shareholders, or do risks remain? Roland Head looks at the latest numbers. Read More »
-
Should I buy Novacyt shares at under 400p?
The Novacyt share price is rising today, but 45% of the company's 2020 sales are under dispute. Can the company stage a post-Covid recovery? Read More »
-
Can the Novacyt (NCYT) share price make a comeback?
The Novacyt (NCYT) share price has had a rough year, falling by nearly 60% since January. But is it about to make a comeback?... Read More »
-
What’s happening to the Novacyt share price?
The Novacyt share price surged 6,000% in 2020. But this year, the stock has plummeted. Zaven Boyrazian investigates what’s happened. Read More »
-
The Novacyt share price plunges 10%! Here’s why
The Novacyt share price is plunging today as the company may have to revise its revenue figures lower due to a contract dispute. Read More »